IE (15 μg) pr. ml, bør der tilføjes humant serumalbumin (HSA) til en slutkoncentration på 2 mg/ ml.
For patients treated with filgrastim diluted to concentrations below 1.5 MIU (15 μ g) per ml, human serum albumin (HSA) should be added to a final concentration of 2 mg/ ml.